Moderna Shares Surge 18.35% in Three Days, Trading Volume Ranks 53rd

On May 20, 2025, Moderna (MRNA) shares surged by 6.06%, marking the third consecutive day of gains and a total increase of 18.35% over the past three days. The trading volume reached $1.048 billion, placing it 53rd in the day's market activity.

Moderna's stock price jumped following the Food and Drug Administration's (FDA) approval of the COVID-19 booster shot for individuals aged 65 and older, as well as those with underlying health conditions. This regulatory update was seen as favorable by investors, as it addressed concerns about the potential elimination of COVID boosters, a significant revenue stream for Moderna.

Analysts noted that the new FDA guidelines do not fundamentally alter the vaccine policy for older and high-risk Americans, which helped to ease investor concerns. The market's reaction to this news was significant, with Moderna's shares experiencing a notable increase, reflecting the market's positive sentiment towards the company's prospects.